Fresenius SE Total Assets 2016-2024 | FSNUY

Fresenius SE total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Fresenius SE total assets for the quarter ending June 30, 2024 were $46.859B, a 43.76% decline year-over-year.
  • Fresenius SE total assets for 2023 were $49.011B, a 39.13% decline from 2022.
  • Fresenius SE total assets for 2022 were $80.511B, a 5.44% decline from 2021.
  • Fresenius SE total assets for 2021 were $85.138B, a 11.83% increase from 2020.
Fresenius SE Annual Total Assets
(Millions of US $)
2023 $49,011
2022 $80,511
2021 $85,138
2020 $76,130
2019 $75,047
2018 $66,966
2017 $60,056
2016 $51,398
2015 $47,936
Fresenius SE Quarterly Total Assets
(Millions of US $)
2024-06-30 $46,859
2024-03-31 $48,078
2023-12-31 $49,011
2023-09-30 $81,987
2023-06-30 $83,321
2023-03-31 $82,172
2022-12-31 $80,511
2022-09-30 $80,906
2022-06-30 $80,998
2022-03-31 $82,049
2021-12-31 $85,138
2021-09-30 $83,819
2021-06-30 $83,927
2021-03-31 $83,145
2020-12-31 $76,130
2020-09-30 $79,867
2020-06-30 $76,586
2020-03-31 $76,090
2019-12-31 $75,047
2019-09-30 $74,236
2019-06-30 $72,980
2019-03-31 $73,810
2018-12-31 $66,966
2018-09-30 $64,789
2018-06-30 $65,572
2018-03-31 $65,765
2017-12-31 $60,056
2017-09-30 $62,405
2017-06-30 $58,181
2017-03-31 $57,993
2016-12-31 $51,398
2016-09-30 $48,773
2016-06-30 $49,500
2016-03-31 $46,825
2015-12-31 $47,936
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.704B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00